Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (IS) (2016 - 2019)

Xtant Medical Holdings has reported Depreciation & Amortization (IS) over the past 10 years, most recently at $137000.0 for Q3 2019.

  • Quarterly Depreciation & Amortization (IS) fell 86.69% to $137000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2019, down 66.64% year-over-year, with the annual reading at $4.1 million for FY2018, 24.92% down from the prior year.
  • Depreciation & Amortization (IS) was $137000.0 for Q3 2019 at Xtant Medical Holdings, down from $146000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (IS) peaked at $2.1 million in Q4 2015 and troughed at $100663.0 in Q2 2015.
  • The 5-year median for Depreciation & Amortization (IS) is $1.2 million (2016), against an average of $989765.5.
  • Year-over-year, Depreciation & Amortization (IS) soared 3606.51% in 2015 and then plummeted 86.69% in 2019.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $2.1 million in 2015, then crashed by 39.11% to $1.3 million in 2016, then increased by 10.36% to $1.4 million in 2017, then decreased by 24.35% to $1.0 million in 2018, then tumbled by 86.88% to $137000.0 in 2019.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation & Amortization (IS) are $137000.0 (Q3 2019), $146000.0 (Q2 2019), and $159000.0 (Q1 2019).